All In Biotech

Drugs by condition

Drugs approved for chronic hives (urticaria)

Brand-name prescription drugs and biologics whose FDA label lists chronic hives (urticaria) as an approved use. Matched on the label phrases: "urticaria".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

13

Still marketed, NDA or BLA

Drug classes

5

Novel drugs

3

New molecular entities and new biologics

In development

18

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for chronic hives (urticaria).

  • Omlyclo (Omalizumab-Igec) · Celltrion INC Mar 7, 2025
  • Quzyttir (Cetirizine Hydrochloride) · Esteve Oct 4, 2019
  • Dupixent (Dupilumab) · Regeneron Pharmaceuticals NovelBreakthrough therapyPriority reviewOrphanMar 28, 2017
  • Epinephrine (Epinephrine) · Bpi Labs Jul 29, 2014
  • Adrenalin (Epinephrine) · Ph Health Dec 18, 2013

All approved drugs for chronic hives (urticaria), by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 105 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

alpha-Adrenergic Agonist (6)

Anti-IgE (2)

  • Xolair Omalizumab · Genentech · 2003
  • Omlyclo Omalizumab-Igec · Celltrion INC · 2025

Interleukin-4 Receptor alpha Antagonist (1)

  • Dupixent Dupilumab · Regeneron Pharmaceuticals · 2017

Histamine-1 Receptor Antagonist (1)

  • Clarinex Desloratadine · Organon · 2001

Class not listed in FDA's data (3)

  • Quzyttir Cetirizine Hydrochloride · Esteve · 2019
  • Karbinal Er Carbinoxamine Maleate · Aytu · 2013
  • Gastrocrom Cromolyn Sodium · Viatris Specialty · 1996

Drugs in development for chronic hives (urticaria)

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • PovorcitinibINCB054707, INCB54707Phase 312 trials

    Incyte · Hidradenitis Suppurativa (HS), NonSegmental Vitiligo, Prurigo Nodularis

  • CM512Phase 39 trials

    Keymed Biosciences Co.Ltd · Chronic Rhinosinusitis With Nasal Polyposis, Chronic Spontaneous Urticaria (CSU), Asthma

  • LP-003SinglePhase 39 trials

    Longbio Pharma · Allergic Asthma, Chronic Spontaneous Urticaria (CSU), Peanut Allergies

  • TLL-018Phase 38 trials

    Hangzhou Highlightll Pharmaceutical Co., Ltd · Chronic Spontaneous Urticaria (CSU), Rheumatoid Arthritis, Chronic Spontaneous Urticaria

  • barzolvolimabCDX-0159Phase 37 trials

    Celldex Therapeutics · Chronic Spontaneous Urticaria, Chronic Inducible Urticaria, Cold Urticaria

  • MG-K10Humanized Monoclonal AntibodyPhase 36 trials

    Shanghai Mabgeek Biotech.Co.Ltd · Dermatitis, Atopic, Chronic Urticaria, Idiopathic, Atopic Dermatitis

  • JYB1904RPT904, ozureprubartPhase 35 trials

    Jemincare · Chronic Spontaneous Urticaria, Perennial Allergic Rhinitis, Immune System Diseases

  • ICP-332Phase 34 trials

    Beijing InnoCare Pharma Tech Co., Ltd. · Non Segmental Vitiligo, Chronic Spontaneous Urticaria (CSU), Atopic Dermatitis

  • Shanghai Mabgeek Biotech.Co.Ltd · Atopic Dermatitis, Seasonal Allergic Rhinitis, Chronic Spontaneous Urticaria (CSU)

  • AK139Phase 26 trials

    Akeso · Asthma, Moderate-to-Severe Atopic Dermatitis, Chronic Spontaneous Urticaria

  • EVO756Phase 24 trials

    Evommune, Inc. · Migraine, Chronic Inducible Urticaria, Atopic Dermatitis

  • BLU-808Phase 22 trials

    Blueprint Medicines Corporation · Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, Allergic Rhinoconjunctivitis

  • BBT001Phase 21 trial

    Bambusa Therapeutics · Chronic Spontaneous Urticaria

  • BriquilimabJSP191Phase 21 trial

    Jasper Therapeutics, Inc. · Chronic Spontaneous Urticaria

  • HRS-3095Phase 21 trial

    Chengdu Suncadia Medicine Co., Ltd. · Chronic Spontaneous Urticaria

  • HS-10561Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Spontaneous Urticaria

  • LesigerceptPhase 21 trial

    Yuhan Corporation · Allergic Diseases, Chronic Spontaneous Urticaria (CSU)

  • NN2802Phase 21 trial

    Novelty Nobility, Inc. · Healhty, Chronic Spontaneous Urticaria (CSU)

1 discontinued brand-name drugs whose label still names it
  • Xyzal Levocetirizine Dihydrochloride

More on chronic hives (urticaria): recruiting trials · published research

Related in immunology and inflammation: Rheumatoid arthritis · Plaque psoriasis · Psoriatic arthritis · Atopic dermatitis (eczema) · Crohn's disease · Ulcerative colitis · Ankylosing spondylitis · Lupus (SLE) · Hidradenitis suppurativa · Alopecia areata

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.